General
Preferred name
STEARIC ACID
Synonyms
Cetylacetic acid ()
Octadecanoic acid ()
Octadecanoic acid, Isostearic acid, Cetylacetic acid ()
Hydrogenated tallow acid ()
Stearate ()
Palmitostearic acid ()
Hydrogenated tallow acids ()
Hystrene 7018 ()
Hydrogenated tallow acid, beef ()
Dervacid 3155 ()
Pristerene 4916 ()
Pristerene 4981 ()
NSC-25956 ()
Kolliwax s fine ()
Neo-fat 18-57 ()
E570 ()
Hydrogenated tallow fatty acids ()
Stearic acid 70 ()
Hyfac 420 ()
Hydrofol acid 150 ()
N-octadecanoic acid ()
Edenor htict-n ()
Tallow, acids, hydrogenated ()
Prifac 5905 ()
Century 1210 ()
Purified stearic acid ()
Pristerene 4910 ()
Sterene 460 ()
Tallow fatty acids, hydrogenated ()
Pristerine 4989 ()
Hyfac 410 ()
Sterene 60b ()
Barolub fta ()
Hyfac 421 ()
Tallow, hydrogenated fatty acids ()
NSC-261168 ()
Sterene 60r ()
FEMA NO. 3035 ()
Stearic acid 50 ()
Neo-fat 18-58 ()
Adeka sa 300 ()
Fatty acids, hydrogenated tallow ()
Hyfac 422 ()
Tallow acid, hydrogenated ()
Stearic Acid-d35 ()
Stearic Acid-13C ()
Stearic Acid-d2 ()
Stearic Acid-9,10-d2 ()
Stearic Acid-d4 ()
Stearic Acid-d5 ()
Stearic Acid-13C18 ()
P&D ID
PD007733
CAS
609343-71-7
68937-76-8
134503-33-6
57-11-4
126539-56-8
17660-51-4
85541-42-0
19905-58-9
57396-97-1
130048-57-6
211443-83-3
287100-83-8
Tags
available
drug
Approved by
FDA
Drug Status
approved
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
TOXICITY Acute oral toxicity (LD50): 4640 mg/kg [Rat]. Acute dermal toxicity (LD50): >5000 mg/kg [Rabbit].; ;
DESCRIPTION Stearic acid is a long-chain dietary saturated fatty acid that can significantly reduce visceral fat by inducing apoptosis of preadipocytes. Stearic acid can be used in the study of cardiovascular and metabolic diseases[1].
PRICE 90
DESCRIPTION Stearic acid is one of the useful types of saturated fatty acids that comes from many animal and vegetable fats and oils. It is used as an ingredient found in topical products as a skin protectant. (Enamine Bioactive Compounds)
DESCRIPTION 1. Stearic acid (Cetylacetic acid) can reduce metastatic tumor burden. 2. Stearic acid leads to dramatically reduced visceral fat likely by causing the apoptosis of preadipocytes. 3. Stearic acid and its derivatives have been used as gelators in food and pharmaceutical gel formulations. 4. Stearic acid is a potent phosphatase 1B inhibitor, possibly causing an enhancement in the insulin receptor signaling to stimulate glucose uptake into adipocytes. 5. Stearic acid has the potential to increase dry matter intake and yields of milk and milk components, without affecting conversion of feed to milk, body condition score, or body weight. (TargetMol Bioactive Compound Library)
Compound Sets
18
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
Enamine Bioactive Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NPC Screening Collection
Nuisance compounds in cellular assays
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
ZINC Tool Compounds
External IDs
109
Properties
(calculated by RDKit )
Molecular Weight
284.27
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
1
Rotatable Bonds
16
Ring Count
0
Aromatic Ring Count
0
cLogP
6.33
TPSA
37.3
Fraction CSP3
0.94
Chiral centers
0.0
Largest ring
0.0
QED
0.34
Structural alerts
1
Surfactant
Nuisance compounds
Custom attributes
(extracted from source data)
Target
Endogenous Metabolite
Tyrosine Phosphatase 1B
Environmental Pollutants
MOA
Tyrosinase
Pathway
Apoptosis
Metabolic Enzyme/Protease
Metabolism
Source data